SkylineDX Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
75
- Latest Deal Type
-
Later Stage VC
- Investors
-
6
SkylineDX General Information
Description
Developer of diagnosis technology designed to offer gene signature-based diagnostic test services. The company's technology determines the type or status of the disease and predicts a patient's response to a specific treatment for individualized medical care, based on the genomic profile of the disease, enabling care providers and patients to get help in decision-making on whether a therapy will work or surgery is necessary.
Contact Information
Website
www.skylinedx.comCorporate Office
- Lichtenauerlaan 40
- Brainpark II - Building XI
- 3062 ME Rotterdam
- Netherlands
Corporate Office
- Lichtenauerlaan 40
- Brainpark II - Building XI
- 3062 ME Rotterdam
- Netherlands
SkylineDX Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 01-Jan-2024 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 21-Dec-2021 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 02-Sep-2019 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 26-Jul-2018 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 05-Jan-2009 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 05-Oct-2007 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 01-Jan-2005 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
SkylineDX Comparisons
Industry
Financing
Details
SkylineDX Competitors (26)
One of SkylineDX’s 26 competitors is AliveDx, a Formerly VC-backed company based in Eysins, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AliveDx | Formerly VC-backed | Eysins, Switzerland | ||||
| Foundation Medicine | Formerly VC-backed | Boston, MA | ||||
| Decipher Urologic Cancers | Formerly VC-backed | San Diego, CA | ||||
| Myriad Genetics | Corporation | Salt Lake City, UT | ||||
| Agendia | Venture Capital-Backed | Irvine, CA |
SkylineDX Patents
SkylineDX Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4133490-A1 | Method for identifying signatures for predicting treatment response | Inactive | 06-Apr-2020 | ||
| US-20230223107-A1 | Method for identifying signatures for predicting treatment response | Pending | 06-Apr-2020 | ||
| WO-2021206544-A1 | Method for identifying signatures for predicting treatment response | Inactive | 06-Apr-2020 | ||
| AU-2019310636-A1 | Gene signatures for predicting metastasis of melanoma and patient prognosis | Active | 25-Jul-2018 | ||
| AU-2019310636-B2 | Gene signatures for predicting metastasis of melanoma and patient prognosis | Active | 25-Jul-2018 | C12Q1/6886 |
SkylineDX Signals
SkylineDX Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Amsterdam UMC Ventures Holding | Venture Capital | Minority | ||
| Novalis LifeSciences | Venture Capital | Minority | ||
| Utrecht Holdings | Not-For-Profit Venture Capital | Minority | ||
| Van Herk Groep | Real Estate | Minority | ||
| Erasmus MC Biomedical Fund | Venture Capital | Minority |
SkylineDX Investments (1)
SkylineDX’s most recent deal was a Later Stage VC with DCPrime. The deal was made on 28-Oct-2014.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| DCPrime | 28-Oct-2014 | Later Stage VC | Drug Discovery |
SkylineDX FAQs
-
When was SkylineDX founded?
SkylineDX was founded in 2005.
-
Where is SkylineDX headquartered?
SkylineDX is headquartered in Rotterdam, Netherlands.
-
What is the size of SkylineDX?
SkylineDX has 75 total employees.
-
What industry is SkylineDX in?
SkylineDX’s primary industry is Diagnostic Equipment.
-
Is SkylineDX a private or public company?
SkylineDX is a Private company.
-
What is SkylineDX’s current revenue?
The current revenue for SkylineDX is .
-
How much funding has SkylineDX raised over time?
SkylineDX has raised $29.1M.
-
Who are SkylineDX’s investors?
Amsterdam UMC Ventures Holding, Novalis LifeSciences, Utrecht Holdings, Van Herk Groep, and Erasmus MC Biomedical Fund are 5 of 6 investors who have invested in SkylineDX.
-
Who are SkylineDX’s competitors?
AliveDx, Foundation Medicine, Decipher Urologic Cancers, Myriad Genetics, and Agendia are some of the 26 competitors of SkylineDX.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process